BAYN — Bayer AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapValue Trap

Annual balance sheet for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,404	11,883	7,739	10,153	10,587
Net Total Accounts Receivable
Net Total Receivables	14,851	12,157	12,980	13,450	12,522
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,439	35,675	32,578	37,760	37,556
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,479	11,723	12,688	13,674	13,321
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	126,174	116,804	120,241	124,877	116,259
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,215	36,768	29,403	35,084	29,457
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	78,921	86,281	87,221	86,104	83,332
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	47,253	30,523	33,020	38,773	32,927
Total Liabilities & Shareholders' Equity	126,174	116,804	120,241	124,877	116,259
Total Common Shares Outstanding